Evidence map›Paper›PMID 11709363›Full record

ArticleAntimicrobial agents and chemotherapy2001

Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro.

S W Kamau, F Grimm, A B Hehl

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Reporter gene systems: A powerful tool forCurrent research in microbial sciences · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Visceral leishmaniasis: experimental models for drug discovery.The Indian journal of medical research · 2011
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Leishmania amastigotes as targets for drug screening.Kinetoplastid biology and disease · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S W KamauInstitute of Parasitology, University of Zürich, CH-8057 Zürich, Switzerland.
F Grimm
A B Hehl

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transgenic Leishmania infantum promastigotes, which constitutively express green fluorescent protein (GFP) in their cytoplasm, were used to monitor the effects of antileishmanial compounds in real time. The GFP-based assay provided a reliable measure of drug-induced inhibitory effects on protein expression, resulting in a dynamic picture of the responses of leishmanial promastigotes to the compounds tested.

Indexed as

AllopurinolAnimalsAntiprotozoal AgentsBiomarkersCycloheximideGreen Fluorescent ProteinsLeishmania infantumLuminescent ProteinsProtein Synthesis InhibitorsPuromycinAllopurinolAntiprotozoal AgentsBiomarkersCycloheximideGreen Fluorescent ProteinsLuminescent ProteinsProtein Synthesis InhibitorsPuromycin

Identifiers

PMID11709363
PMCPMC90892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.